ISOTAMINE 100 MG
ISONIAZID : 100 MG · DIN 00261270 · BAUSCH HEALTH, CANADA INC.
Health Canada status: DORMANT
What is ISOTAMINE?
ISOTAMINE 100 MG contains ISONIAZID : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00261270, held by BAUSCH HEALTH, CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 07-Dec-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ISOTAMINE used for?
Isoniazid is used in conjunction with at least one other antituberculosis agent in the treatment of clinical tuberculosis and other mycobacterial diseases. It is also used for the prevention of tuberculosis in various at-risk populations, including household contacts of infected individuals, those with significant Mantoux tuberculin skin test reactions, and individuals with certain medical conditions or immunosuppression.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00261270 |
|---|---|
| Brand name | ISOTAMINE |
| Generic / active ingredient | ISONIAZID : 100 MG |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J04AC01 ISONIAZID |
| AHFS class | 86:16.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 07-Dec-2020 |
| Original market date | 1969-12-31 00:00:00 |
How is it stored and handled?
Isoniazid tablets should be stored in well-closed, light-resistant containers at controlled room temperature (15 - 30 °C). When stored in filled unopened containers at a temperature not exceeding 25 °C, the syrup is expected to retain its potency for 1 year.
How is it supplied?
ISOTAMINE Tablets: Bottles of 100 and 1000 tablets. ISOTAMINE Syrup: Bottles of 500 mL. ISOTAMINE Powder: Each bottle contains: 500 g powder.
What can be used instead?
Other Canadian products sharing ATC code J04AC01 ISONIAZID. 3 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PDP-ISONIAZID | 100 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00577790 |
| PDP-ISONIAZID | 300 MG | Tablet | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00577804 |
| PDP-ISONIAZID | 50 MG / 5 ML | SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 00577812 |
| DOM-ISONIAZID 300MG TABLETS | 300 MG | TABLET | DOMINION PHARMACAL | CANCELLED POST MARKET | DIN 02181428 |
| ISONIAZID SYRUP 50MG/5ML | 50 MG / 5 ML | SYRUP | CAROLINA MEDICAL PRODUCTS COMPANY | CANCELLED POST MARKET | DIN 00722464 |
| ISONIAZID TAB 100MG | 100 MG | TABLET | SANDS PHARM | CANCELLED POST MARKET | DIN 00440108 |
| ISONIAZID TAB 300MG | 300 MG | TABLET | SANDS PHARM | CANCELLED POST MARKET | DIN 00310247 |
| ISONIAZID TAB 50MG | 50 MG | TABLET | SANDS PHARM | CANCELLED POST MARKET | DIN 00382779 |
| ISONIAZIDE 100MG TABLETS | 100 MG | TABLET | LABORATOIRES CONFAB INC | CANCELLED PRE MARKET | DIN 02232756 |
| ISOTAMINE | 10 MG | SYRUP | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00265500 |
Who else supplies ISONIAZID worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ISONIAZID appears in 683 registered pack listings across 10 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.